Method of expressing thymys peptide alpha by yeast and use thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- ZHEJIANG UNIV PHARM CO LTD
- Publication Date
- 2004-02-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to biological technology, relates to genetic engineering, especially relates to a method for expressing thymosin α1 by yeast, and is suitable for adjuvant treatment of diseases caused by hypofunction of thymus. Background technique
[0002] The thymus is an important immune organ in the body and plays an important role in the development of the lymphatic system and maintaining the normal function of the immune system. Especially in anti-infection, anti-tumor, transplantation and autoimmune diseases, it has special significance. As the body ages, the thymus gradually shrinks and degenerates, and the incidence of tumors, infections, and immune diseases gradually increases. A large number of studies have shown that the calf thymus extract (containing thymosin) can be used as an adjuvant treatment for tumors, infections and other diseases caused by hypofunction of the thymus. However, since the thymus extract of animals is a mixed c...